首页> 外文期刊>Nephron >Regulation of Epithelial Sodium Channel in Puromycin Aminonucleoside-Induced Unilateral Experimental Nephrotic Syndrome in Normal and Analbuminemic Nagase Rats
【24h】

Regulation of Epithelial Sodium Channel in Puromycin Aminonucleoside-Induced Unilateral Experimental Nephrotic Syndrome in Normal and Analbuminemic Nagase Rats

机译:嘌呤霉素氨基核苷酸诱导的正常和厌氨性长濑大鼠的单侧实验性肾病综合征中上皮钠通道的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Nephrotic syndrome (NS) is characterized by renal sodium retention and edema formation. In nephrotic rats the site of enhanced sodium retention has been localized in the cortical collecting duct (CCD). The epithelial sodium channel (ENaC) isthe rate-limiting constituent of sodium transport in CCD. Amiloride, an ENaC-blocking drug, corrects the abnormal rate of sodium transport in isolated perfused CCD from puromycin aminonucleoside (PAN)-treated rats. Therefore, we hypothesized that ENaC functional expression is increased in NS. Methods: Unilateral NS was induced by PAN in Wistar rats and analbuminemic Nagase rats (NAR). Urinary protein excretion, renal abundance of mRNA and protein of ENaC subunits, as well as the ENaC regulatory serum glucocorticoid-inducible kinase (Sgk1) and Nedd4-2, were assessed. Results: Proteinuria appeared at day 2 in the Wistar rats and NAR. Surprisingly a downregulation rather than the expected upregulation of a-, beta- and 7-ENaC mRNA abundance was observed in both Wistar rats and NAR, when the treated kidney was compared with the untreated kidney. The amount of protein of alpha-, beta- and gamma-ENaC was not affected by the NS. Sgk1 mRNA expression did not change and Nedd4-2 protein expression was only decreased at days 1 and 2 in Wistar rats. Conclusion: ENaC mRNA and protein expression are not increased in the early phase of unilateral PAN-induced NS. Sgk1, Nedd4-2 and analbuminemia are not important regulatory factors of ENaC protein expression in experimental NS.
机译:背景:肾病综合征(NS)的特征是肾钠retention留和水肿形成。在肾病大鼠中,钠保留增加的部位已经定位在皮质收集管(CCD)中。上皮钠通道(ENaC)是CCD中钠转运的限速成分。阿米洛利是一种ENaC阻断药,可纠正嘌呤霉素氨基核苷(PAN)处理的大鼠的离体灌注CCD中钠转运的异常率。因此,我们假设ENaC功能表达在NS中增加。方法:PAN分别诱导Wistar大鼠和厌氧性纳豆酶(NAR)大鼠单侧NS。评估了尿蛋白排泄,ENaC亚基的mRNA和蛋白的肾脏丰度,以及ENaC调节血清糖皮质激素诱导的激酶(Sgk1)和Nedd4-2。结果:Wistar大鼠和NAR在第2天出现蛋白尿。令人惊讶的是,当将治疗肾脏与未治疗肾脏进行比较时,在Wistar大鼠和NAR中均观察到a-,β-和7-ENaC mRNA丰度的下调而不是预期的上调。 NS,α-,β-和γ-ENaC的蛋白质量不受影响。在Wistar大鼠中,Sgk1 mRNA表达没有变化,Nedd4-2蛋白表达仅在第1天和第2天下降。结论:单侧PAN诱导的NS早期ENaC mRNA和蛋白表达没有增加。 Sgk1,Nedd4-2和白蛋白血症不是实验性NS中ENaC蛋白表达的重要调节因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号